M K el-Yosef, D S Janowsky, J M Davis, H J Sekerke. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Brain/drug effectsChlorpromazine/therapeutic useFemaleHumansImipramine/therapeutic useMemory, Short-Term/drug effectsParasympatholytics/adverse effectsPerphenazine/therapeutic usePhysostigmine/therapeutic useSchizophrenia/drug therapyThioridazine/therapeutic use
Substances： See more » ParasympatholyticsPhysostigminePerphenazineThioridazineImipramineChlorpromazine
Year: 1972 PMID： 5066746 DOI： 10.1001/jama.1972.03200010109024
Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272